Your browser doesn't support javascript.
loading
Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Pharaon, Momen; Tichet, Mélanie; Lebrun-Frénay, Christine; Tartare-Deckert, Sophie; Passeron, Thierry.
Affiliation
  • Pharaon M; Department of Dermatology, Archet 2 Hospital, Centre Hospitalier Universitaire (CHU) Nice, Nice, France.
  • Tichet M; Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, Team 11, Centre Méditerranéen de Médecin Moléculaire (C3M), Nice, France.
  • Lebrun-Frénay C; Department of Neurology, Pasteur Hospital, CHU Nice, Nice, France.
  • Tartare-Deckert S; Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, Team 11, Centre Méditerranéen de Médecin Moléculaire (C3M), Nice, France.
  • Passeron T; Department of Dermatology, Archet 2 Hospital, Centre Hospitalier Universitaire (CHU) Nice, Nice, France4INSERM, U1065, Team 12, C3M, Nice, France.
JAMA Dermatol ; 150(8): 901-3, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24919481

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Antibodies, Monoclonal, Humanized / Immunologic Factors / Melanoma / Nevus Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Dermatol Year: 2014 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Antibodies, Monoclonal, Humanized / Immunologic Factors / Melanoma / Nevus Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Dermatol Year: 2014 Document type: Article Affiliation country: France Country of publication: United States